elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q37136989-110294E0-DDEA-4E08-B66E-4E5595F9A1A4
Q37136989-110294E0-DDEA-4E08-B66E-4E5595F9A1A4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37136989-110294E0-DDEA-4E08-B66E-4E5595F9A1A4
Bortezomib in mantle cell lymphoma.
P2860
Q37136989-110294E0-DDEA-4E08-B66E-4E5595F9A1A4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37136989-110294E0-DDEA-4E08-B66E-4E5595F9A1A4
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
33ec080a63bfd4d95ce9c874e23e159c7aa64b7e
P2860
Bendamustine plus rituximab is effective and has a favorable toxicity profile in the treatment of mantle cell and low-grade non-Hodgkin's lymphoma.